Author details

Full Name

Homayoon Khanlou

Affiliation

ORCID

Career Start Year

1996

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
25127924	Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.	AIDS Research and Human Retroviruses	2014
23247363	Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California.	AIDS and Behavior	2013
23362296	SWIFT: prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen.	Clinical Infectious Diseases	2013
23088336	Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naÃ¯ve patients in the ARTEMIS trial.	HIV Medicine	2013
22407303	TMP/SMX is still the preferred empiric antibiotic for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in the HIV population.	Journal of acquired immune deficiency syndromes (1999)	2012
21684853	Similar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients.	HIV Clin Trials	2011
21430236	Use of maraviroc-, raltegravir-, and etravirine-containing regimens in treatment-experienced patients: a case-series study.	Journal of the International Association of Physicians in AIDS Care	2011
21317583	Clinical impact and cost of laboratory monitoring need review even in resource-rich setting.	Journal of acquired immune deficiency syndromes (1999)	2011
21774689	Barriers and unmet need for supportive services for HIV patients in care in Los Angeles County, California.	AIDS Patient Care and STDs	2011
20304235	DART and laboratory monitoring of HIV treatment.	Lancet, The	2010
20809839	The 104 day report: a successful intervention of improving patient retention.	Clinical Infectious Diseases	2010
21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	Science	2010
20220339	An unusual pathogen for a liver abscess in a human immunodeficiency virus-infected individual.		2010
20035167	Avoid a different standard of care when applying results of Development of Antiretroviral Therapy in Africa (DART) study.	Journal of acquired immune deficiency syndromes (1999)	2010
19369697	Analysis of a switch from enfuvirtide to raltegravir in patients with undetectable viral load: efficacy and quality of life at 24 weeks.	Journal of the International Association of Physicians in AIDS Care	2009
19219022	Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.	Nat Med	2009
19171916	The use of darunavir/ritonavir as intensification in low viremic HIV-infected patients treated with boosted protease inhibitor-containing regimens.	Journal of the International Association of Physicians in AIDS Care	2009
19622053	Maraviroc: a new CCR5 antagonist.	Expert Review of Anti-Infective Therapy	2009
18936290	Meningitis due to hematogenous dissemination of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in a patient with AIDS.	Journal of the International Association of Physicians in AIDS Care	2008
19164138	No residual activity of raltegravir after development of 148 complex mutations in vivo.	Journal of the International Association of Physicians in AIDS Care	2008
18474495	Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine.	HIV Clinical Trials	2008
18614861	Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.	AIDS	2008
18662108	Raltegravir: the first in a new class of integrase inhibitors for the treatment of HIV.	Expert Review of Anti-Infective Therapy	2008
18362696	False-positivity of HIV-2 immunoblots in a cohort of elite suppressors infected with HIV-1.	Journal of acquired immune deficiency syndromes (1999)	2008
17766779	Peripheral Neuropathy Induced by Lopinavir-Saquinavir-Ritonavir Combination Therapy in an HIV-Infected Patient.	Journal of the International Association of Physicians in AIDS Care	2007
16832008	The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.		2006
16340485	Interaction between atazanavir and fosamprenavir in the treatment of HIV-infected patients.	Journal of acquired immune deficiency syndromes (1999)	2006
16987045	Long-term follow-up of patients with initial early virologic failure after being treated with once-daily tenofovir/abacavir/lamivudine.	AIDS Patient Care and STDs	2006
15793377	Efficacy of tenofovir as intensification of zidovudine/lamivudine/abacavir fixed-dose combination in the treatment of HIV-positive patients.	Journal of acquired immune deficiency syndromes (1999)	2005
15757454	Tipranavir: a novel second-generation nonpeptidic protease inhibitor.	Expert Review of Anti-Infective Therapy	2005
16010179	Co-administration of atazanavir with proton-pump inhibitors and H2 blockers.	Journal of acquired immune deficiency syndromes (1999)	2005
15798380	Early virologic failure in a pilot study evaluating the efficacy of therapy containing once-daily abacavir, lamivudine, and tenofovir DF in treatment-naive HIV-infected patients.	AIDS Patient Care and STDs	2005
12659366	Relationship between mitral valve regurgitant flow and peripartum change in systemic vascular resistance.	Southern Medical Journal	2003
11964539	Drug interaction between amprenavir and lopinavir/ritonavir in salvage therapy.	AIDS	2002
11248717	Safety and efficacy of heliox as a treatment for upper airway obstruction due to radiation-induced laryngeal dysfunction.	Heart and Lung: Journal of Acute and Critical Care	2001
11694843	Heterogeneity of patients' adherence profile to antiretroviral therapy in HIV-infected patients.	Journal of acquired immune deficiency syndromes (1999)	2001
11112251	Reduction of buffalo hump by switching to amprenavir in an HIV-infected patient.		2000
10836764	Development of Kaposi sarcoma despite sustained suppression of HIV plasma viremia.	Journal of acquired immune deficiency syndromes (1999)	2000
10761970	Idiopathic adulthood ductopenia: case report and review of the literature.		2000
10875291	Echocardiographic parameters in reversible idiopathic dilated cardiomyopathy.	American Journal of the Medical Sciences	2000
10593352	Long-term remission of refractory stiff-man syndrome after treatment with intravenous immunoglobulin.	Mayo Clinic Proceedings	1999
9892272	Massive subfascial hematoma after alteplase therapy for acute myocardial infarction.	American Journal of the Medical Sciences	1999
10084174	Jejunal telangiectasias as a cause of massive bleeding in a patient with scleroderma.		1999
10037117	Resolution of adult respiratory distress syndrome after recovery from fulminant hepatic failure.	American Journal of the Medical Sciences	1999
9676804	Fatal alveolar hemorrhage and Abciximab (ReoPro) therapy for acute myocardial infarction.		1998
9867573	Abciximab and alveolar hemorrhage.	New England Journal of Medicine	1998
9777380	Schwannoma of posterior mediastinum: a case report and concise review.	Heart and Lung: Journal of Acute and Critical Care	1998
9238442	[Characteristics of rapid progressors in HIV infection].	Annales de Medecine Interne	1997
8774393	Polymyositis in HTLV-I infected patient.	Journal of Internal Medicine	1996